Preventive effects of multi-lamellar emulsion on low potency topical steroid induced local adverse effect

Annals of Dermatology

Volumn 25, Issue 1, 2013, Pages 5-11

  Sul, Geun Dong ^a   Park, Hyun Jung ^b   Bae, Jong Hwan ^b   Hong, Keum Duck ^b   Park, Byeong Deog ^b   Chun, Jaesun ^a   Jeong, Se Kyoo ^b   Lee, Seung Hun ^c   Ahn, Sung Ku ^d   Kim, Hyun Jung ^e  

^a Korea National University of Education   (South Korea)

^b NeoPharm Co Ltd   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d Yonsei University Wonju College of Medicine   (South Korea)

^e Atopy and Asthma Center ^*  (South Korea)

Author keywords

Epidermal permeability barrier function; Multilamellar emulsion; Skin permeation; Topical glucocorticoids

Indexed keywords

EID: 84877288282     PISSN: 10139087     EISSN: 20053894     Source Type: Journal    
DOI: 10.5021/ad.2013.25.1.5     Document Type: Article

References (18)

1. Sheu HM, Lee JY, Chai CY, Kuo KW. Depletion of stratum corneum intercellular lipid lamellae and barrier function abnormalities after long-term topical corticosteroids. Br J Dermatol 1997;136:884-890.
2. Kao JS, Fluhr JW, Man MQ, Fowler AJ, Hachem JP, Crumrine D, et al. Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities. J Invest Dermatol 2003;120:456- 464.
3. Lubach D, Rath J, Kietzmann M. Skin atrophy induced by initial continuous topical application of clobetasol followed by intermittent application. Dermatology 1995;190:51-55.
4. Lubach D, Bensmann A, Bornemann U. Steroid-induced dermal atrophy. Investigations on discontinuous application. Dermatologica 1989;179:67-72.
5. Lubach D, Rath J, Kietzmann M. Steroid-induced dermal thinning: discontinuous application of clobetasol-17-propionate ointment. Dermatology 1992;185:44-48.
6. Korting HC, Unholzer A, Schäfer-Korting M, Tausch I, Gassmueller J, Nietsch KH. Different skin thinning potential of equipotent medium-strength glucocorticoids. Skin Pharmacol Appl Skin Physiol 2002;15:85-91.
7. Kaidbey K, Kopper SC, Sefton J, Gibson JR. A pilot study to determine the effect of tazarotene gel 0.1% on steroid-induced epidermal atrophy. Int J Dermatol 2001;40:468-471.
8. Hebert AA, Cook-Bolden FE, Basu S, Calvarese B, Trancik RJ; Desonide Hydrogel Study Group. Safety and efficacy of desonide hydrogel 0.05% in pediatric subjects with atopic dermatitis. J Drugs Dermatol 2007;6:175-181.
9. Kircik L, Del Rosso J. A novel hydrogel vehicle formulated for the treatment of atopic dermatitis. J Drugs Dermatol 2007;6:718-722.
10. Ahn SK, Bak HN, Park BD, Kim YH, Youm JK, Choi EH, et al. Effects of a multilamellar emulsion on glucocorticoidinduced epidermal atrophy and barrier impairment. J Dermatol 2006;33:80-90.
11. Park BD, Youm JK, Jeong SK, Choi EH, Ahn SK, Lee SH. The characterization of molecular organization of multilamellar emulsions containing pseudoceramide and type III synthetic ceramide. J Invest Dermatol 2003;121:794-801.
12. Park BD, Kim Y, Lee M, Youm JK, Jeong S, Choi EH, et al. Properties of a pseudoceramide multi-lamellar emulsion in vitro and in vivo. Cosmet Toiletry 2001;116:65-76.
13. Park BD, Lee M, Kim Y, Youm JK. Synthesis of N-ethanol-2- (myristyl/palmityl)-3-oxo(stearamide/arachidamide) and its physicla properties for a cosmetic raw material. J Cosmet Sci 2000;51:253-262.
14. Lee EJ, Shur KB, Lee JH, Park JK, Jin CY, Youm JK, et al. The clinical efficacy of a multi-lamellar emulsion containing pseudoceramide in childhood atopic dermatitis: an open crossover study. Ann Dermatol 2003;15:133-138.
15. Elias PM. Stratum corneum defensive functions: an integrated view. J Invest Dermatol 2005;125:183-200.
16. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002;347:1151- 1160.
17. Jang BC, Lim KJ, Suh MH, Park JG, Suh SI. Dexamethasone suppresses interleukin-1beta-induced human beta-defensin 2 mRNA expression: involvement of p38 MAPK, JNK, MKP-1, and NF-kappaB transcriptional factor in A549 cells. FEMS Immunol Med Microbiol 2007;51:171-184.
18. Aberg KM, Radek KA, Choi EH, Kim DK, Demerjian M, Hupe M, et al. Psychological stress downregulates epidermal antimicrobial peptide expression and increases severity of cutaneous infections in mice. J Clin Invest 2007;117:3339- 3349.